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Abstract
Background: Sexually transmitted infections (STIs) increase HIV infectivity through local inflammatory processes.
Prevalent and incident STIs among people who live with HIV/AIDS (PLWHA) are indicators of high-risk sexual behaviors
and imply potential spread of HIV. Little is known about the prevalence and incidence of concurrent syphilis and
associated risk behaviors among PLWHA in China.
Methods: A retrospective cohort study was conducted among PLWHA who attended the outpatient clinic of
a designated AIDS treatment hospital in Shenyang, China, between March 2009 and May 2013. Physical examinations
and syphilis serology were conducted at each visit. A questionnaire on demographic characteristics was also collected.
Results: A total of 1010 PLWHA were enrolled, of whom 77.0% were men who have sex with men (MSM). The baseline
syphilis prevalence among PLWHA was 19.8% (95% confidence interval [CI]:17.3–22.3%). During follow-up, 78.3% retained
in the cohort, and contributed a median follow-up of 9.4 months (interquartile range: 5.9-18.7 months). Syphilis incidence
among PLWHA was 18.7 (95% CI: 15.5–21.8) per 100 person years. Mulitvariate logistic analysis showed that receiving
antiretroviral therapy (ART) (adjusted OR [aOR] = 0.48), older age (≥40 years vs. ≤24 years, aOR = 2.43), being MSM
(aOR = 2.30) and having higher baseline HIV viral load (>100000 copies/mL vs. ≤100000 copies/mL, aOR = 1.56) were
independent predictors for syphilis infection among PLWHA at enrollment (p < 0.05 for all). Mulivariate Cox regression
found that receiving ART (adjusted hazard ratio [aHR] = 1.81), older age (≥40 years vs. ≤24 years, aHR: 5.17) and MSM
status (aHR = 2.68) were independent risk factors for syphilis seroconversion (each p < 0.05).
Conclusions: Syphilis prevalence and incidence were high among PLWHA in Shenyang. A campaign focusing on
detection and treatment of syphilis among PLWHA is urgently needed, especially one with a focus on MSM who are
at a higher risk for syphilis.
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Background
China has witnessed a rapid increase of sexually transmit-
ted infections (STIs), including syphilis and HIV in the past
decade [1,2]. The national sentinel surveillance in 2009
showed that syphilis prevalence was 2.4% among female
sex workers (FSWs), 3.4% among people who inject drugs
(PWID), and 9.1% among men who have sex with men
(MSM) [1]. The population prevalence of syphilis in China
was 32.0 per 100,000 people in 2011 [3] which was over 7
times as high as that in the US (4.5 per 100,000 people) [4]
and the UK (5.6 per 100,000 people) [5]. In 2008, the preva-
lence of active syphilis among MSM was 12.2% in China,
which was lower than that in Thailand (21.6%) but higher
than that in Indonesia (4.0%) [6]. Sexual transmission had
become the major route of HIV transmission in China in
recent years [7]. Of 70,000 newly reported HIV/AIDS cases
in the first nine months of 2013, heterosexual transmission
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accounted for 69.1% and MSM transmission accounted for
20.8% of all cases [8].
Globally the majority of HIV prevention programs
usually focus on HIV negative individuals who are at high
risk for HIV infection [9,10]. However, recently resear-
chers realized that it may be more efficient to prevent
HIV if we target people living with HIV/AIDS (PLWHA)
(“positive prevention”), as they really serve as the sources
of HIV transmission [11]. A meta-analysis showed that
positive preventions were efficacious in reducing unpro-
tected sex and acquisition of STIs [12]. The concept of
Treatment as prevention strategy was raised and investi-
gated quite intensively in recent years, and antiretroviral
therapy (ART) can remarkably decrease the risk of trans-
mitting HIV through reducing viral load (VL) among
PLWHA [13,14]. HIV-1 RNA in seminal plasma may
decline more slowly than that in blood and could
be detected with undetectable HIV-1 RNA in blood
plasma when PLWHA experience ART [15,16], which
points to the potential risk for HIV transmission via
unprotected sexual behaviors. Moreover, ART may
lead to complacent as people feel that they may live a
long life with HIV and restore sexual desire as well as
physical and immunological functions [17,18]. Because
of sharing a common mode of sexual transmission,
syphilis and HIV infection have significant epidemic
synergistic. Syphilis incidence is considered an indica-
tor of high-risk sexual behaviors [19,20]. Therefore, it
is useful to understand the risk for HIV transmission
among PLWHA by measuring their risk for syphilis trans-
mission [21]. In addition, among individuals diagnosed
with HIV who are not yet eligible for ART, treatment of
co-infections including syphilis may offer an important
alternative approach to reducing HIV VL and decreasing
HIV transmission risk [22]. Little is known about the risk
for syphilis transmission among PLWHA and its correl-
ation with ART and sexual behaviors [23]. In this retro-
spective cohort study we aimed to evaluate both syphilis
prevalence and incidence among PLWHA in Northeast
China.
Methods
Study population and participants enrollment
This retrospective cohort study was conducted among
HIV-infected patients in Shenyang City in Northeast
China. HIV status was based on positive test results from
two peripheral blood samples by HIV ELISA and confirmed
by western blot (Gene labs Diag. Singapore). All HIV test-
ing sites were certified by the National AIDS Reference
Laboratory at China CDC. Participants were recruited from
The First Affiliated Hospital of China Medical University
(CMU), which was one of two designated hospitals provid-
ing free ART in Shenyang City. Since 2002, PLWHA in
China with a CD4
+ T cell counts of 200 cells/mm3 or less,
total lymphocyte counts of less than 1200 cells/mm3, or
WHO disease stage 3 or 4 have been eligible for free com-
bination antiretroviral therapy. In 2008, the CD4
+ T cell
counts threshold for treatment was increased to 350 cells/
mm3 [24]. Between March 2009 and May 2013, patients
who were scheduled for a regular visit at the HIV out-
patient clinic in The First Affiliated Hospital of CMU were
invited to participate in a baseline assessment. Eligible par-
ticipants were those who: were 18 years or older and were
able and willing to provide written informed consent. Base-
line syphilis serological test was conducted to assess preva-
lent syphilis. Syphilis un-infected patients were followed up
every 6 months to assess incident syphilis. During the
follow-up, we calculated survival as time from baseline initi-
ation to syphilis seroconversion or censoring. Patients were
censored at dropout, loss to follow-up, or on May 31, 2013,
whichever came first. Those who were diagnosed with syph-
ilis infection were referred to the STI clinic in the same hos-
pital for treatment. Figure 1 shows the study procedures.
Ethical approval was obtained from the institutional
review board of The First Affiliated Hospital of CMU
prior to the commencement of the study.
Figure 1 Procedure of enrollment and follow-up. A total of 1302 participants were invited, 243 did not meet enrollment criteria, 49 declined
enrollment. A total of 1010 participants were included at baseline. Of the 810 participants who were syphilis seronegative at baseline, 634 completed
at least one follow-up visit.
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Table 1 Characteristics of PLWHA with prevalent and incident syphilis in Shenyang















Overall 1010 200 19.8 634 702.3 131 18.7
Gender
Female 68 4 5.9 51 40.6 3 7.4
Male 942 196 20.8 583 661.8 128 19.3
Age (year)
Median(IQR) 35(27-46) 35(27-46)
≤24 142 22 15.5 92 124.8 8 6.4
25-39 461 77 16.7 299 353.7 43 12.2
≥40 407 101 24.8 243 223.9 80 35.7
Ethnicity
Han 883 182 20.6 552 607.0 115 19.0
Other ethnicities 127 18 14.2 82 95.3 16 16.8
Marital status
Single 522 102 19.5 317 376.0 54 14.4
Married 330 62 18.8 213 219.3 44 20.1
Divorced 158 36 22.8 104 107.1 33 30.8
Occupation
Employed 645 129 20.0 415 461.3 90 19.5
Unemployed 198 36 18.2 123 120.0 24 20.0
Retired 76 22 29.0 43 46.5 14 30.1
Student 91 13 14.3 53 74.7 3 4.0
Education
Less than high school 351 77 21.9 209 225.4 46 20.4
High school or more 659 123 18.7 425 476.9 85 17.8
Shenyang resident
Yes 885 181 20.5 560 601.4 115 19.1
No 125 19 15.2 74 100.9 16 15.9
HIV transmission route
Heterosexual 146 16 11.0 103 88.2 15 17.0
MSM 778 171 22.0 478 570.0 111 19.5
Others (injection drug use,
blood, unknown)
86 13 15.1 53 44.2 5 11.3
HIV diagnosis venue
VCT 277 54 19.5 182 244.9 41 16.7
Hospital 366 87 23.8 242 281.3 59 21.0
Others (blood donation,
physical exam, etc.)
57 6 10.5 48 70.0 5 7.2
Unknown 310 53 17.1 162 106.2 26 24.5
ART at baseline
No 687 159 23.1 385 501.0 68 13.6
Yes 323 41 12.7 249 201.3 63 31.3
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Data collection
At baseline, patients were asked to self-complete an an-
onymous questionnaire on demographic characteristics,
HIV history including date and venues of HIV diagnosis,
transmission route, and ART experience. HIV VL and
CD4
+ T cell counts were also tested as part of regular care.
The blood specimens collected at baseline and 6-monthly
follow-up visits were also tested for syphilis infection.
After explanation of study, informed consent was obtained
from all participants.
Laboratory testing
Syphilis screening serological test was performed using
rapid plasma reagin (RPR; Shanghai Kehua Bio-engineering
Co., Ltd, China). Positive RPR results were confirmed
using Treponema Pallidum particle assay (Serodia TPPA;
Fujirebio, Tokyo, Japan). Subjects who were plasma posi-
tive for both TPPA and RPR were considered as current
infection. RPR negative participants at baseline who
turned to be positive for both TPPA and RPR at follow-up
visits were defined as syphilis seroconversion event. In
addition, TPPA negative participants at baseline who
turned to be TPPA positive were eligible for syphilis sero-
conversion during the follow-up period. CD4
+ T cell counts
were determined by flow cytometry (BD Bioscience San
Diego, CA, USA). Plasma HIV-1 RNA copy was measured
by a commercial HIV RNA quantitative detection assay,
COBAS AmpliPrep/COBAS TaqMan HIV-1 Test (Roche,
Germany), with a detection limit of 40 copies/mL in
plasma. All tests were performed according to the manu-
facturers’ instructions.
Data analysis
Demographic and HIV history variables were compared
between participants with prevalent syphilis at baseline
and those without; and between those who seroconverted
during follow-up and those who did not. We analyzed
covariates including sex, age (≤24, 25–39, and ≥40 years),
ethnicity, marital status, occupation, education, HIV
transmission route (heterosexual, MSM and others),
HIV diagnosis venues (voluntary counseling and testing
[VCT], hospital, others and unknown), baseline CD4
+ T cell
counts (<200, 200-349, 350–499, and ≥500 counts/mm3),
baseline VL (≤100000 and >100000 copies/mL). Logistic
regression was performed to assess factors associated with
prevalent syphilis infection at baseline. Cox proportional
hazard regression was used to determine the adjusted haz-
ard ratio (aHR) for factors associated with incident syphilis
infection. Syphilis seroconversion was estimated to occur
at the midpoint of the interval between the last negative
test and the subsequent follow-up positive test. Syphilis
incidence rate and its 95% confidence interval (CI) were
calculated assuming Poisson distribution. Variables with
P < 0.20 in univariate analysis were included in the multi-
variate logistic or Cox regression models. Only variables
with P < 0.05 were kept in the final multivariate models.
Double data entries were performed using EpiData
software (The Epi Data Association Odense, Denmark,
version 3.02). Data were analyzed using SAS 9.1 (SAS
Institute Inc., Cary, NC).
Results
Demographic characteristics of study participants
As shown in Figure 1, a total of 1302 PLWHA who were
registered at the HIV clinic were invited to participate in
the study, 243 did not meet enrollment criteria, 49 de-
clined enrollment. Therefore a total of 1010 participants
were included in the estimation of HIV prevalence at
baseline. Of the 810 participants who were syphilis sero-
negative at baseline, 78.3% (634/810) completed at least
one follow-up visit and contributed a median follow-up of
9.4 months (interquartile range [IQR]: 5.9-18.7 months).
Table 1 Characteristics of PLWHA with prevalent and incident syphilis in Shenyang (Continued)
Time since HIV diagnosis (year)
≤2 730 156 21.4 439 514.1 79 15.4
>2 280 44 15.7 195 188.2 52 27.6
Baseline CD4
+ T cell counts(counts/mm3)
≥500 152 28 18.4 95 126.3 20 21.1
350-499 255 40 15.7 173 194.1 41 23.7
200-349 331 62 18.7 214 226.7 36 16.8
<200 246 65 26.4 142 137.7 30 21.1
Unknown 26 5 19.2 10 17.5 4 40.0
Baseline VL (copies/mL)
≤100,000 599 118 19.7 378 455.6 77 16.9
>100,000 148 46 31.1 72 85.5 13 15.2
Unknown 263 36 13.7 184 161.2 41 25.4
IQR: interquartile range; VCT: voluntary counseling and testing; ART: antiretroviral therapy; VL: viral load; PY: person year.
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Table 2 Factors associated with syphilis infection at baseline among PLWHA in Shenyang
Factor OR (95% CI) P-value Adjusted OR (95% CI) P-value
Gender
Female 1.00
Male 4.20 (1.51 –11.69) 0.006
Age(year)
≤24 years 1.00
25-39 years 1.09 (0.65 -1.83) 0.734 1.26 (0.74 –2.12) 0.395
≥40 years 1.80 (1.08 -2.99) 0.023 2.43 (1.42 –4.15) 0.001
Ethnicity
Han 1.00
Other ethnicities 0.64 (0.38 –1.08) 0.091
Marital status
Single 1.00
Married 0.95 (0.67 –1.35) 0.786
Divorced 1.22 (0.79 –1.87) 0.375
Occupation
Employed 1.00
Unemployed 0.89 (0.59 –1.34) 0.573
Retired 1.63 (0.96 –2.77) 0.072
Student 0.67 (0.36 –1.24) 0.199
Education
Less than high school 1.00
High school or more 0.82 (0.59 –1.12) 0.214
Shenyang resident
Yes 1.00
No 0.70 (0.42 –1.17) 0.170
HIV transmission route
Heterosexual 1.00
MSM 2.29 (1.33 –3.95) 0.003 2.30 (1.30 –4.08) 0.004
Others (injection drug use,
blood, unknown)
1.45 (0.66 –3.18) 0.357 1.33 (0.59 –2.97) 0.488
HIV Diagnosis venue
VCT 1.00
Hospital 1.29 (0.88 –1.89) 0.195 1.42 (0.94 –2.13) 0.095
Others (blood donation,
physical exam, etc.)
0.49 (0.20 –1.19) 0.115 0.63 (0.25 –1.56) 0.314
Unknown 0.85 (0.56 –1.30) 0.453 0.75 (0.49 –1.17) 0.208
ART at baseline
No 1.00
Yes 0.48 (0.33 –0.70) <0.001 0.48 (0.31 –0.73) 0.001
Time since HIV diagnosis (year)
≤2 1.00
> 2 0.69 (0.48 –0.99) 0.044
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Table 1 shows the demographic characteristics and
HIV history stratified by syphilis serostatus at baseline
and syphilis seroconversion during follow-up. At baseline,
the median age was 35 years (IQR: 27-46); 87.4% were eth-
nic Han; 93.3% were male; 87.6% were Shenyang residents,
34.8% had an education of high school or higher; 51.7%
were single, 32.7% were currently married and 15.6% were
divorced; 77.0% self-reported as being MSM.
Just over a quarter (27.4%) of participants had been
diagnosed with HIV at VCT venues, 36.2% in hospitals,
and the rest through other ways such as HIV/AIDS re-
search projects. Nearly one third (32.0%) had prior ART.
At baseline 15.1%, 25.3%, 32.8% and 24.4% had a CD4
+ T
cell counts of ≥500, 350-499, 200-349 and <200 cells/mm3,
respectively. CD4
+ T cells were not detected in 2.6%
of participants. At baseline 59.3% and 14.7% had a
VL of ≤100,000 and >100,000 copies/mL, respectively. VL
was not detected in 26.0% of participants.
Factors associated with seropositivity of syphilis at baseline
The baseline seroprevalence of syphilis was 19.8% (95% CI:
17.3–22.3%). Table 2 illustrates the factors associated with
baseline syphilis infection. In the final multivariate logistic
regression model, ART experience was negatively associ-
ated with syphilis infection (adjusted OR [aOR] = 0.48, 95%
CI: 0.31–0.73), but older age (≥40 years vs. ≤24 years)
(aOR = 2.43, 95% CI: 1.42–4.15), being MSM (aOR =
2.30, 95% CI: 1.30–4.08), and having higher baseline VL
(>100,000 copies/mL vs. ≤100000 copies/mL) (aOR = 1.56,
95% CI: 1.02–2.40) were independently associated with a
higher risk of syphilis infection (each p < 0.05).
Factors associated with seroconversion of syphilis during
follow-up
Of the 634 eligible participants for syphilis incidence
estimation, 131 (20.7%) seroconverted during follow-
up. The incidence rate was 18.7 (95% CI: 15.5–21.8) per
100 person years (PY). Table 3 shows factors associated
with syphilis seroconversion. ART experience (adjusted
hazard ratio [aHR] = 1.81, 95% CI: 1.25–2.62), older age
(≥40 years vs. ≤24 years) (aHR = 5.17, 95% CI: 2.47–
10.84), and being MSM (aHR: 2.68, 95% CI: 1.53–4.69)
were independently associated with syphilis seroconver-
sion (each p < 0.05).
Discussion
STIs pose considerable health threats to PLWHA. In this
study, we report on the first evaluation of both syphilis
prevalence and incidence among an HIV-infected cohort
in northeast China. The prevalence among PLWHA in
Shenyang (19.8%) is much higher than that among
PLWHA in Taiwan (5.7%) [25], Guangzhou (10.5%) [26]
and Liuzhou City (11.4%) [27] in China. It is also higher
than the average syphilis prevalence among PLWHA
from a Meta analysis (9.5%) [28]. Syphilis incidence among
Shenyang PLWHA (18.7/100 PY) is significantly higher
than that in Seoul, South Korea (4.57/100 PY) [29], and
higher than the syphilis incidence among Sichuan PWID
(4.71/100 PY) [30] and Xichang FSWs (6.23/100 PY) [31].
Syphilis can generate genital ulcers and increase the
likelihood of HIV virus shedding. Additionally syphilis
co-infection among PLWHA can increase the concentra-
tion of HIV RNA in blood plasma and decrease the
number of CD4
+ T cell counts [22], and may increase the
risk for HIV transmission [32]. It’s highly likely that high
prevalent and incident syphilis may contribute to the
spread of HIV which is a new threat to HIV prevention.
Our findings provide important information to the deve-
lopment of syphilis screening and treatment program for
PLWHA across China. Syphilis is a marker of unsafe
sexual practices [20,21], and therefore the high syphilis
prevalence and incidence indicated that PLWHA who had
already known self HIV positive status may still engage in
unprotected sex. Behavioral intervention can reduce HIV
transmission risk among HIV positive MSM [33]. Efficient
education programs including safer sexual behavioral
interventions are urgently needed to reduce risk for STIs
transmission among PLWHA in China.
Table 2 Factors associated with syphilis infection at baseline among PLWHA in Shenyang (Continued)
Baseline CD4
+ T counts(counts/ mm3)
≥500 1.00
350-499 0.82 (0.48 –1.40) 0.475
200-349 1.02 (0.62 –1.67) 0.935
<200 1.59 (0.97 –2.62) 0.068
Unknown 1.05 (0.37 –3.04) 0.922
Baseline VL(copies/mL)
≤100000 1.00
>100000 1.84 (1.23 -2.75) 0.003 1.56 (1.02 –2.40) 0.040
Unknown 0.65 (0.43 -0.97) 0.035 0.82 (0.54 –1.26) 0.361
VCT: voluntary counseling and testing; ART: antiretroviral therapy; VL: viral load.
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Table 3 Factors associated with syphilis seroconversion among PLWHA in Shenyang
Factor HR (95% CI) P-value Adjusted HR (95% CI) P-value
Gender
Female 1.00
Male 3.39 (1.08 –10.65) 0.037
Age (year)
≤24 years 1.00
25-39 years 1.79 (0.84 -3.81) 0.131 1.86 (0.87 –3.98) 0.108
≥40 years 4.85 (2.34 -10.05) <0.001 5.17 (2.47 –10.84) <0.001
Ethnicity
Han 1.00
Other ethnicities 0.91 (0.54 –1.53) 0.713
Marital status
Single 1.00
Married 1.31 (0.88 –1.95) 0.183
Divorced 2.00 (1.29 –3.08) 0.002
Occupation
Employed 1.00
Unemployed 0.98 (0.62 –1.54) 0.924
Retired 1.58 (0.90 –2.77) 0.112
Student 0.23 (0.07 –0.72) 0.012
Education
Less than high school 1.00
High school or more 0.89 (0.62 –1.27) 0.503
Shenyang resident
Yes
No 0.89 (0.53 –1.51) 0.676
HIV transmission route
Heterosexual 1.00
MSM 1.45 (0.84 –2.49) 0.181 2.68 (1.53 –4.69) 0.001
Others (injection drug use,
blood, unknown)
0.68 (0.25 –1.87) 0.455 0.63 (0.23 –1.75) 0.376
HIV Diagnosis venue
VCT 1.00
Hospital 2.82 (1.13 -7.03) 0.026 2.08 (0.83 –5.22) 0.120
Others (blood donation,
physical exam, etc.)
2.34 (0.92 -5.91) 0.073 1.92 (0.76 –4.87) 0.171
Unknown 3.05 (1.17 -7.98) 0.023 2.55 (0.97 –6.74) 0.058
ART at baseline
No 1.00
Yes 1.81 (1.27 –2.57) 0.001 1.81 (1.25 –2.62) 0.002
Time since HIV diagnosis (year)
≤2 1.00
> 2 1.57 (1.10 –2.23) 0.012
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Conflicting results are provided by studies analyzing
the association between ART experience and STIs trans-
mission [34-36]. Our data show that the syphilis seroposi-
tive rate among ART patients was significantly lower than
that among treatment naïve patients. The possible reasons
for this may include: unrecovered immune status, degen-
erative sexual desires and lower frequency of unprotected
sexual behaviors. Our study further shows that PLWHA
who took ART had significantly increased syphilis inci-
dence. This is consistent with the findings by Stolte, et al.
in Amsterdam [34], but inconsistent with that by Huang,
et al. in Taiwan [37]. Though ART correlate with substan-
tially lowered HIV RNA levels and decreased HIV infec-
tiveness among PLWHA [13,14], apart from beneficial
clinical effects, treatment advances may have unintended
effects on sexual behavior. Some evidence suggests that
since ART became available, the prevalence of unprotected
sex [34,38] have increased. Sexually transmitted co-infec-
tions increase HIV infectiveness through local inflamma-
tory processes and offset the ART treatment effect as being
HIV secondary prevention. These findings suggest that,
with the expansion of ART in China, health education,
behavioral interventions and STIs monitoring should be
strengthened among ART patients.
MSM (vs. heterosexual), current use of ART at baseline,
and older age (≥40 vs. ≤24 years) were independently
correlated with baseline syphilis infection. MSM status is
also a risk factor for incident syphilis infection, which is
consistent with the literature [36,39]. In China MSM
accounted for 0.3% of the total reported HIV/AIDS cases
in 2006. This figure rapidly increased to 13.0% in 2011 [7].
A large number of MSM engage in unprotected sexual be-
haviors and multiple sexual partnership [40,41] which
place them at risk for both HIV and syphilis infections.
Our findings suggest that HIV-infected MSM should be
given priority to receive syphilis screening and treatment
in Shenyang city.
This study found that the participants aged 40 or older
had a significantly higher risk for syphilis than patients
aged 24 or younger. HIV infections among the elderly
have become increasingly common in China in recent
years [7,42,43]. The possible reasons for higher risks for
HIV and STIs among elderly may include increasing use
of commercial sex, infrequent condom use and low uptake
of STIs testing [42-44].
Our study has limitations. Firstly, we did not collect
data on sexual behaviors and therefore couldn’t evaluate
the relationship between syphilis and sexual behaviors.
Secondly, the participants were a convenience sample of
PLWHA who lived in Shenyang city. Results from this
study may not represent all individuals who are living
with HIV/AIDS in China. Thirdly, higher loss to follow-
up is another challenge in our study. By the end of the
study period, about 21.7% of the participants were lost
to follow-up, and this may cause selection bias. Fourthly,
because HIV and syphilis are sensitive topic for partici-
pants, this study cannot exclude social desirability bias.
Our study, with data on both syphilis prevalence and in-
cidence in HIV-infected population, provides significant
evidence for improving HIV/STIs prevention interven-
tions and care, albeit with above-mentioned limitations.
Conclusions
The prevalence and incidence of concurrent syphilis
were both moderately high among PLWHA in Northeast
China. Results from this program suggest that receiving
ART, older age, and MSM status were independent risk
factors for both prevalent and incident syphilis infection.
Interventions focusing on the detection and treatment of
syphilis are urgently needed for PLWHA in China,
especially MSM who are at high risk for syphilis.
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